# Staccato Alprazolam in Panic Attack

> **NCT00477451** · PHASE2 · COMPLETED · sponsor: **Alexza Pharmaceuticals, Inc.** · enrollment: 49 (actual)

## Conditions studied

- Treatment of Induced Panic Attack

## Interventions

- **DRUG:** Inhaled placebo
- **DRUG:** Inhaled alprazolam 1 mg
- **DRUG:** Inhaled alprazolam 2 mg
- **DRUG:** IV doxapram

## Key facts

- **NCT ID:** NCT00477451
- **Lead sponsor:** Alexza Pharmaceuticals, Inc.
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477451, "Staccato Alprazolam in Panic Attack". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00477451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*